Keyphrases
Pancreatic Cancer
100%
Combined Treatment
100%
Mithramycin
100%
Synergistic Antitumor Activity
100%
Tolfenamic Acid
100%
Pancreatic Cancer Treatment
75%
Antitumor Activity
50%
Combination Treatment
50%
Tumor
25%
Vascular Endothelial Growth Factor
25%
Anti-angiogenesis
25%
Tumor Growth
25%
Dose Effect
25%
Therapy Regimen
25%
Tumor Xenograft
25%
Transcription Factor Sp1
25%
Sp1 Protein
25%
Synergistic Effect
25%
Antitumor Effect
25%
Human Pancreatic Cancer
25%
Protein Degradation
25%
Anticancer Immune Response
25%
Pancreatic Tumor
25%
Systemic Side Effects
25%
Pancreatic Tissue
25%
Antiproliferation
25%
Targeting Strategies
25%
Response Mechanism
25%
Synergistic Therapeutic Effect
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antitumor Activity
100%
Pancreas Cancer
100%
Mithramycin
100%
Tolfenamic Acid
100%
Vasculotropin
25%
Neoplasm
25%
Malignant Neoplasm
25%
Side Effect
25%
Tumor Growth
25%
Clinical Study
25%
Therapeutic Effect
25%
Pancreas Tumor
25%
Transcription Factor Sp1
25%
Pregnancy Specific Beta1 Glycoprotein
25%